|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 410.06 USD | -0.08% |
|
+1.87% | -13.17% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 95.18B 90.7B 84.37B 75.27B 134B 8,066B 147B 1,048B 389B 3,305B 358B 350B 14,198B | P/E ratio 2024 * |
15.2x | P/E ratio 2025 * | 12.5x |
|---|---|---|---|---|---|
| Enterprise value | 116B 110B 102B 91.36B 163B 9,789B 179B 1,272B 472B 4,011B 434B 424B 17,233B | EV / Sales 2024 * |
0.66x | EV / Sales 2025 * | 0.6x |
| Free-Float |
99.81% | Yield 2024 * |
1.58% | Yield 2025 * | 1.68% |
More valuation ratios
* Estimated data
More news
Last Transcript: Elevance Health, Inc.
More recommendations
More press releases
More news
| 1 day | -0.12% | ||
| 1 week | +1.67% | ||
| Current month | +0.42% | ||
| 1 month | -2.20% | ||
| 3 months | -27.32% | ||
| 6 months | -24.70% | ||
| Current year | -13.34% |
1 week
400.44
412.34
1 month
391.02433.38
Current year
391.02567.26
1 year
391.02567.26
3 years
391.02567.26
5 years
171.03567.26
10 years
114.85567.26
| Director | Title | Age | Since |
|---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 2017-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 2023-10-31 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | 2024-02-04 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ramiro Peru
BRD | Director/Board Member | 68 | 2004-11-29 |
Robert Dixon
BRD | Director/Board Member | 68 | 2011-06-30 |
Lewis Hay
BRD | Director/Board Member | 68 | 2013-06-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.22% | 20 M€ | +16.27% | - | |
| 2.36% | 1,439 M€ | +18.43% | - | |
| 2.07% | 7 M€ | +13.24% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.09% | +1.67% | -15.41% | +3.46% | 95.18B | ||
| -0.00% | -0.04% | +10.63% | +35.00% | 560B | ||
| -0.01% | +0.50% | +28.05% | +68.45% | 93.75B | ||
| +0.23% | -1.04% | -40.54% | -30.63% | 35.3B | ||
| -0.36% | -0.76% | -19.57% | -16.20% | 30.32B | ||
| +3.79% | +4.71% | -14.97% | +8.70% | 17.27B | ||
| +0.82% | +5.30% | +72.73% | -11.81% | 2.46B | ||
| -0.73% | -0.15% | +240.39% | -21.05% | 1.72B | ||
| -2.28% | 0.00% | -56.61% | -68.01% | 1.33B | ||
| -0.12% | +2.65% | - | - | 488M | ||
| Average | +0.12% | +0.57% | +22.74% | -3.57% | 83.78B | |
| Weighted average by Cap. | +0.05% | +2.22% | +6.39% | +29.58% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 175B 167B 155B 138B 246B 14,839B 271B 1,928B 716B 6,081B 658B 643B 26,122B | 187B 178B 166B 148B 264B 15,871B 290B 2,062B 765B 6,504B 704B 688B 27,938B |
| Net income | 6.34B 6.04B 5.62B 5.02B 8.92B 538B 9.82B 69.84B 25.92B 220B 23.83B 23.3B 946B | 7.53B 7.18B 6.68B 5.95B 10.59B 638B 11.66B 82.91B 30.77B 261B 28.29B 27.66B 1,123B |
| Net Debt | 20.34B 19.39B 18.03B 16.09B 28.62B 1,724B 31.5B 224B 83.14B 706B 76.43B 74.72B 3,035B | 17.75B 16.91B 15.73B 14.04B 24.97B 1,504B 27.48B 195B 72.54B 616B 66.69B 65.19B 2,648B |
More financial data
* Estimated data
Employees
104,900
Sector
Managed Healthcare
Calendar
2024-12-04
- Détachement de
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-03 | 409.46 $ | -0.23% | 371,776 |
| 24-12-02 | 410.39 $ | +0.84% | 2,030,482 |
| 24-11-29 | 406.96 $ | +1.05% | 1,580,944 |
| 24-11-27 | 402.75 $ | +0.20% | 1,179,428 |
| 24-11-26 | 401.96 $ | -1.38% | 1,611,238 |
Delayed Quote Nyse, December 03, 2024 at 11:22 am EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
410.39USD
Average target price
520.12USD
Spread / Average Target
+26.74%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ELV Stock